Search

Search Constraints

You searched for: Author/Creator Amerio, P.

Search Results

1. A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis. (17th February 2022)

2. A 52‐week update of a multicentre real‐life experience on effectiveness and safety of risankizumab in psoriasis. (19th September 2021)

3. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16‐week real‐life experience during the COVID‐19 pandemic. (8th November 2020)

5. Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real‐life study. (19th January 2021)

6. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. (1st June 2019)

7. Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience. (21st February 2019)

9. HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa. (5th March 2019)

10. Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry. (17th March 2015)